Organic radical contrast agents for magnetic resonance imaging. - Test2 - elhamkhani - TriplyDB

Organic radical contrast agents for magnetic resonance imaging.

Organic radical contrast agents for magnetic resonance imaging.

http://www.wikidata.org/entity/Q30565003

about

bcTol : a highly water-soluble biradical for efficient dynamic nuclear polarization of biomolecules.Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging.Synthesis and Electron Spin Relaxation of Tetracarboxylate Pyrroline Nitroxides.Synthesis of unnatural amino acids functionalized with sterically shielded pyrroline nitroxides.Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging.Spontaneous Formation of an Air-Stable Radical upon the Direct Fusion of Diphenylmethane to a Triarylporphyrin.Synthesis and reduction kinetics of sterically shielded pyrrolidine nitroxides.Electron paramagnetic resonance: a powerful tool to support magnetic resonance imaging research.Nitroxide-Based Macromolecular Contrast Agents with Unprecedented Transverse Relaxivity and Stability for Magnetic Resonance Imaging of Tumors.Imaging short-lived reactive oxygen species (ROS) with endogenous contrast MRI.A Metal-Free Method for Producing MRI Contrast at Amyloid-β.meso-Hydroxysubporphyrins: A Cyclic Trimeric Assembly and a Stable meso-Oxy Radical.Preparation of Robust Metal-Free Magnetic Nanoemulsions Encapsulating Low-Molecular-Weight Nitroxide Radicals and Hydrophobic Drugs Directed Toward MRI-Visible Targeted Delivery.PEGylated, Water-Soluble, Stable Aminyl Radical.Intramolecular Hydrogen Atom Transfer in Aminyl Radical at Room Temperature with Large Kinetic Isotope Effect.Sterically shielded spin labels for in-cell EPR spectroscopy: analysis of stability in reducing environment.A Supramolecularly Activated Radical Cation for Accelerated Catalytic Oxidation.Reduction kinetics and electrochemistry of tetracarboxylate nitroxides.Activation Effect of Fullerene C60 on the Carbon Dioxide Absorption Performance of Amine-Rich Polypropylenimine Dendrimers.High binding yet accelerated guest rotation within a cucurbit[7]uril complex. Toward paramagnetic gyroscopes and rolling nanomachines.Biocompatibility of Gd-Loaded Chitosan-Hyaluronic Acid Nanogels as Contrast Agents for Magnetic Resonance Cancer Imaging.Polyurethane based organic macromolecular contrast agents (PU-ORCAs) for magnetic resonance imaging Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor Spin Density Distribution in a Nitroxide Biradical Containing 13C-Enriched Acetylene Groups in the Bridge: DFT Calculations and EPR Investigation Nitroxide-radicals–modified gold nanorods for in vivo CT/MRI-guided photothermal cancer therapy

P2860

Q30008921-A5B8091C-E9B1-4EDC-B0CE-4FB5BBE02FBA Q30910766-28EC7488-5E1B-40F1-83F6-9BFC0E1A9E42 Q33817596-786DE373-CEF3-4B19-BB3C-59CB91295194 Q34361003-2063F17F-C594-4071-AE32-DD4743DE1BA1 Q34723882-9101827D-B5D6-4601-8548-674D2E96987C Q36039536-1E73045D-F98F-4822-8C86-752B7BF6901E Q36363981-E4865F74-DB2C-4F73-ACAE-A12B4B4C29E8 Q38264293-A524B078-9C14-421D-A4BB-76C9199F58F5 Q41162546-6212DE4C-B47B-412A-ADB1-1EC39C923D4C Q46366003-DCE749D5-7C30-4BFA-A510-63065348D20D Q46451313-963CDC3C-245A-41C0-B956-EA231FD33575 Q46745056-FC1D0455-707C-4B5D-965A-5A322A11AAC4 Q47193649-A2DE07B8-E0C2-4C1C-BAD9-AC3DBEEBBF2C Q47991321-471B3BC0-59C2-4991-B5D4-BD716B1127B6 Q48130882-828EF0EE-5F13-4E20-8033-0AAA531D129C Q48592144-5640141E-DD7C-4A01-8EF5-FB9671E53209 Q50801390-6BF308D5-B7F0-4FE2-B32E-50D3210FA343 Q51755208-566F7CBB-EE88-4C6D-8F24-70BB4EF09E45 Q51828654-4CB17226-FF95-4746-8B7F-6300F5F748B4 Q53638144-25A628D0-39F9-4E4B-8D27-8B73C746FC19 Q55080578-856728CD-0EF8-4A5C-BEE2-58F7FA73BEF7 Q57369408-F91A3EFC-4883-4579-B76F-B412BA3DF1B6 Q57585475-66C0E747-E3B1-43B0-9FD4-4D6406B93D87 Q57715429-DBE2E00B-DAD3-4973-8CE7-836BB1C50BC6 Q59125645-1DC3DF3D-9D99-43BD-AE75-BD16371D8D58

P2860

Organic radical contrast agents for magnetic resonance imaging.

http://www.wikidata.org/entity/Q30565003

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Organic radical contrast agents for magnetic resonance imaging.

@ast

Organic radical contrast agents for magnetic resonance imaging.

@en

type

label

Organic radical contrast agents for magnetic resonance imaging.

@ast

Organic radical contrast agents for magnetic resonance imaging.

@en

prefLabel

Organic radical contrast agents for magnetic resonance imaging.

@ast

Organic radical contrast agents for magnetic resonance imaging.

@en

P1433

Q30565003-D9DCCDAB-521C-461F-A899-D2A23DA9D6BF

P1476

Q30565003-91C82A54-C59B-4928-90C1-A8E8D661BD98

P2093

Q30565003-40439083-7ACD-41E2-B5A2-200E877B9437

Q30565003-4D760749-8A3D-4223-9148-883D26C33E61

Q30565003-545DEE15-6183-403A-8F89-F7CF9ACA1264

Q30565003-680551A9-6265-4486-B263-C76CA7FEAEF3

Q30565003-796E0818-368D-42BA-9C23-A5FD1D82E6E8

Q30565003-886AC365-2A4A-425B-998A-B9B5FABE645C

Q30565003-955C8B40-94FF-4057-AFE7-71357D99F6DF

Q30565003-BC6A57A8-EC2B-482E-965E-4E14E8EDFD86

Q30565003-CF26E284-321A-4293-8716-F21E9526D01A

Q30565003-EEBC1BBD-DF8F-4BED-8325-E715A18B38C1

P2860

Q30565003-0B21EA48-97A4-4520-A997-4DC4CF44D558

Q30565003-0B38085D-519A-4FAE-A562-B9FFE1012C19

Q30565003-0EFB024B-2A85-4051-B222-B5FF110A7472

Q30565003-2F6AF26C-1421-4675-B181-E8978A1B69CE

Q30565003-56E040D7-F906-4114-9337-1093BF526F9C

Q30565003-5F28AE4F-D292-4628-BCA6-54446F15D135

Q30565003-67AACC8E-7F13-4AC1-A17F-15ADBB7BEAE4

Q30565003-68FCD23F-23D4-40AC-A49C-0CC0A34FF235

Q30565003-6BD98B2A-BE92-448C-8952-8BA436EB4A02

Q30565003-7DF71369-F30B-4CA1-BCF1-DF7EC64D17A5

P304

Q30565003-B872A929-F615-4F8E-BBC1-E3DD6A7B33A6

P31

Q30565003-93C8C581-AB03-4CF3-A2A8-449D956EB796

P356

Q30565003-223CE08B-423B-4203-B7DF-0870F2DC6E7F

P407

Q30565003-58439486-2E86-40F0-9027-0F779BBF4212

P433

Q30565003-68AB37AF-5B26-4575-9E49-2B0217697A59

P478

Q30565003-286036E4-560A-434A-83FA-F272A1ADB301

P577

Q30565003-5721D91F-8703-48C2-B1BE-94D66498F221

P5875

Q30565003-87374DB3-3252-43BC-BB51-E6839E5D99DF

P698

Q30565003-4B0C8F97-632D-4878-8F8E-7E3C8F328DE7

P932

Q30565003-5F158906-8DA2-4418-854A-00CB80E303B3

P356

P1433

Journal of the American Chemical Society

P1476

Organic radical contrast agents for magnetic resonance imaging.

@en

P2093

Andrzej Rajca

http://www.w3.org/2001/XMLSchema#string

Arnon Olankitwanit

http://www.w3.org/2001/XMLSchema#string

Deborah G Mitchell

http://www.w3.org/2001/XMLSchema#string

Gareth R Eaton

http://www.w3.org/2001/XMLSchema#string

Joseph T Paletta

http://www.w3.org/2001/XMLSchema#string

Michael A Swanson

http://www.w3.org/2001/XMLSchema#string

Michael Boska

http://www.w3.org/2001/XMLSchema#string

Sandra S Eaton

http://www.w3.org/2001/XMLSchema#string

Suchada Rajca

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity

Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Targeted dendrimer-based contrast agents for articular cartilage assessment by MR imaging.

The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent.

Potential of albumin labeled with nitroxides as a contrast agent for magnetic resonance imaging and spectroscopy.

Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Nephrogenic systemic fibrosis.

P304

15724-15727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA3079829

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230847601

http://www.w3.org/2001/XMLSchema#string

P698

22974177

http://www.w3.org/2001/XMLSchema#string

P932

3486519

http://www.w3.org/2001/XMLSchema#string